Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with RPRX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
RPRX
Royalty Pharma plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
RPRX
Royalty Pharma plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
RPRX, dashed
LLY
ELI Lilly & Co
Change
1,418.01
▲
+0.03%
· post 1,412.00
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
RPRX
Royalty Pharma plc
Change
67.19
▲
+0.01%
· post 66.62
Closed
Nov 2 '26
Mkt cap
$38.2B
Revenue
$674M
Q2 FY26
Revenue
$2.4B
FY25
vs
Compare
Closed
Nov 2 '26
LLY
ELI Lilly & Co
vs
RPRX
Royalty Pharma plc
1,418.01
▲
+0.03%
post 1,412.00
Price
67.19
▲
+0.01%
post 66.62
$1.3T
Mkt cap
$38.2B
Q3 FY26
$24.4B
Revenue
$674M
Q2 FY26
FY25
$65.2B
Revenue
$2.4B
FY25
Change
Change
LLY
1,418.01
▲
+0.03%
vs
RPRX
67.19
▲
+0.01%
Closed
Nov 2 '26